Boehringer Ingelheim Pharma GmbH & Co. KG
Day by day, more than 50,000 Boehringer Ingelheim employees do their best to improve human and animal health worldwide. As a research-driven pharmaceutical company, Boehringer Ingelheim focuses on diseases for which no satisfactory treatment options are yet available.
Familiy-owned since its foundation in 1885, Boehringer Ingelheim is now one of the 20 leading companies in the industry. In Germany, the company employs more than 15,000 people and is represented at the four sites Ingelheim, Biberach, Dortmund and Hanover.
Boehringer Ingelheim is active in an international network in the research areas of immunology and respiratory diseases, cardiometabolic diseases, oncology and immunoncology and diseases of the central nervous system. In Biberach, the company operates its world\'s largest research and development centre. Here, scientists use state-of-the-art technologies to develop innovative solutions for patients.
Biberach is also the largest cell culture-based biopharmaceutical manufacturing site. Boehringer Ingelheim also offers its know-how to external partners, from development and production to market supply of biopharmaceuticals.
